In this study we show, by immuno¯uorescence and electron microscopy immuno-gold labelling, that the major transforming protein of Human Papillomavirus type 16 E7 is associated with the nucleolus of cells derived from the HPV16-positive cervical carcinoma line CaSki. The E7 nucleolar staining appeared to be cell cycle dependent, being considerably reduced in the G 2 phase. The total level of the protein in the cell, however, remained constant during all phases. We also show that the cellular protein Rb1, which is targeted by E7, is localised in the nucleus and nucleolus in CaSki cells. Thus, it is possible that the presence of E7 in the nucleolus correlates with a hypothetical function(s) of Rb1 in this particular intranuclear compartment. The nucleolar localisation of HPV16 E7 protein was also observed in the ®ssion yeast Schizosaccharomyces pombe, suggesting that a targeting mechanism of HPV16 E7 protein into the nucleolus is common to both mammalian and yeast systems. Nucleolar localisation of HPV16 E7 protein may be independent from Rb1 since no Rb1 related proteins have been identi®ed in ®ssion yeast.
Introduction
Some types of human papillomavirus (HPV) have been implicated in the development of cervical carcinoma. In most cases, HPV16 or 18 DNA can be found in the malignant cells from such tumours (zur Hausen, 1991) . Two early genes of the virus, E6 and E7, are responsible for the malignant conversion of the cell (for review see Mansur and Androphy, 1993; Tommasino and Crawford, 1995) . The E7 gene product, which seems to play a major role in cellular transformation, is a small nuclear phosphoprotein (Smotkin and Wettstein, 1987; Sato et al., 1989) . It co-operates with activated ras gene product in the transformation of primary rodent cells or with E6 protein in the immortalisation of human keratinocytes, the natural host cell for the virus (Mansur and Androphy, 1993) . E7 has been shown to activate the E2F transcription factors via its interaction with thè pocket protein' family, Rb1, p107 and p130 (Dyson et al., 1989; Davies et al., 1993; Hu et al., 1995) . Thè pocket proteins' bind and inhibit E2F transcription factors, which are involved in controlling the expression of several genes required during cell cycle progression (Bandara and La Thangue, 1991; Cao et al., 1992; Chellappan et al., 1991a; Cobrinik et al., 1993; Schwarz et al., 1993) . HPV16 E7/pocket proteins interaction results in a release of free E2F, which can then activate the transcription of genes required in the G 1 /S transition (Phelps et al., 1991; Chellappan et al., 1991b) .
Several ®ndings suggest that`pocket proteins' are not the only cellular targets of E7. For instance, the E7 protein of the benign HPV1 binds to Rb1 with approximately the same anity as HPV16 E7. In spite of this, however, HPV1 E7 does not have any activity in the transformation of rodent primary culture or primary human keratinocyte in co-operation with ras, suggesting that RB1/E7 interaction is not sucient to induce cellular transformation (Ciccolini et al., 1994; Schmitt et al., 1994) . In addition, HV16 E7 mutants which are defective in binding Rb1, when inserted in the entire HPV genome, retained the ability to immortalise primary human keratinocytes (Jewers et al., 1992) . Analogous data were obtained using the cottontail rabbit papillomavirus (CRPV) model. In these studies mutants of CRPV E7, which were not able to bind Rb1, were still capable to induce wart formation in rabbits (Defeo-Jones et al., 1993) . All these data support the idea that E7 impacts upon more than one cellular pathway to induce cellular transformation.
The precise cellular localisation of E7 remains to be elucidated although several pieces of evidence suggest that it is a nuclear protein. For instance, E7 interacts with the Rb1 protein family, which appears to be localised in the nucleus. However, detection of E7 in the nucleus has only been clearly observed in cells which overexpress the protein (Sato et al., 1989) . In cell lines derived from HPV-positive cervical carcinomas (e.g. CaSki and SiHa) such localisation was observed only when the cells were subjected to gentle sequential fractionation (Green®eld et al., 1991) . These data strongly suggest that, under normal physiological conditions the recognition of E7 by the antibody is masked by its interaction with other proteins within the nucleus (Green®eld et al., 1991) . On the other hand, cell fractionation experiments show that the majority of the E7 protein from E7-expressing cells is found in the cytoplasm (Smotkin and Wettstein, 1987) .
We have generated a new series of HPV16 E7 monoclonal antibodies and used to determine the cellular localisation of E7. Immuno¯uorescence and electron microscopy immuno-gold staining of cells derived from cervical carcinoma (CaSki cells), show that E7 is associated with the nucleolus of these cells. Interestingly, when the E7 gene was expressed in ®ssion yeast Schizosaccharomyces pombe (S. pombe), the same cellular localisation was observed, suggesting that the mechanism of transport of E7 protein into the nucleolus maybe common to mammalian and to yeast cells.
Results

Generation of HPV16 E7 monoclonal antibodies
Native HPV16 E7 protein was synthesised in the ®ssion yeast Schizosaccharomyces pombe. Mice were immunised with puri®ed recombinant E7 protein as described in Materials and methods section. The supernatants of four hybridomas resulted to be positive in ELISA, using as antigen the glutathione S-transferase-HPV16 E7 fusion protein (GST/16E7). All four hybridomas were established as lines and named TVGY701, TVGY702, TVGY703, TVGY704. The monoclonal antibodies were further characterised by immunoblot. TVGY701 and 703 were able to strongly react with the GST/16E7 fusion protein, but not with the GST domain alone or with GST/E7 fusion proteins of other HPV types (Figure 1a and b) . A weak reaction was also observed with TVGY702 and GST/ 16E7, while TVGY704 did not seem to recognise any E7 proteins (data not shown). Interestingly, TVGY701 and 703 recognise an epitope which is present in the Nterminal part of HPV16 E7 protein, which is known to be the most immunogenic region of the molecule (Figure 1a and b). TVGY701 and 703 were also able to immunoprecipitate yeast recombinant E7 protein, while TVGY702 and 704 showed in this assay a weak or no activity, respectively (Figure 1c ).
Cellular localisation of HPV16 E7 protein
To locate E7 protein in CaSki, we tested if any of the newly generated monoclonal antibodies were able to stain speci®c compartments of such cells by standard immuno¯uorescence techniques. CaSki cells were ®xed in methanol and incubated with TVGY701 or TVGY703 monoclonal antibodies (see also Materials and methods for more details). A typical pattern of CaSki immuno¯uorescence staining obtained with two dierent monoclonal antibodies is shown in Figure 2A and C. Surprisingly, HPV16 E7 appeared strongly to be associated with the nucleolus. Staining was also observed in the nucleus and in the cytoplasm, although the nuclear staining was more evident with TVGY703 ( Figure 2C ). TVGY703 did not stain nucleoli in HaCaT keratinocytes which are HPV16 negative, suggesting that the staining observed in CaSki with this antibody is speci®c ( Figure 2E ). Analogously, no cell staining was observed when the E7 monoclonal antibody was omitted from the immuno¯uorescence reaction ( Figure 2G ). In order to check if the E7 nucleolar staining could be an artefact caused by the ®xation procedure of CaSki, we have also used a dierent method for ®xing the cell which implies the use of paraformaldehyde (see Materials and methods for more details). A similar nucleolar staining, as previously shown in Figure 2 , was only observed in the HPV16-positive CaSki cells ( Figure 3D ), but not in HaCaT cells ( Figure 3B ). To further con®rm that the nucleolar staining was due to a speci®c reaction between the monoclonal antibody and E7 protein, we have performed the immunofluorescence staining of CaSki in presence of increasing concentration of puri®ed recombinant E7 protein. The addition of 0.5 mg or 6 mg of soluble puri®ed E7 protein in the labelling reaction, ratio antigen/antibody of approximately 0.5 and 7 respectively, decreases or completely abolishes the staining of nucleolus (Figure 4) . The same HPV16 E7 protein localisation was also observed by electron microscopic immuno-gold staining. The cells were treated as described in Materials and methods and stained with TVGY703 monoclonal antibody. HPV16 E7 protein was predominantly localised in the nucleolus in most of the cells ( Figure   TVGY701 TVGY703
Figure 2 HPV16 E7 cellular localisation by immuno¯uorescence. Asynchronous cultures of CaSki (A ± D and G ± H) or HaCaT (E ± F) cells were ®xed in methanol and stained as described in Materials and methods. Immuno¯uorescence staining with TVGY701 (A) and DAPI staining (B). Immuno¯uorescence staining with TVGY703 (C) and phase contrast image (D). Immuno¯uorescence staining with TVGY703 (E) and phase contrast image (F) of HaCaT cells. Immuno¯uorescence staining with secondary antibody 5B). Weaker E7 staining was also observed in the cytoplasm and the nucleus ( Figure 5B ). In all experiments three epithelial cell lines, MCF7, HaCat or C-33A, which do not contain HPV DNA, served as a negative control for E7 protein.
No staining was observed in these cells ( Figure 5A and data not shown). Similar results to those shown in Figure 5A and B were obtained using another anti E7 monoclonal antibody (TVGY701) or a polyclonal antibody raised against the fusion protein MS2/E7 (Tommasino et al., 1990 ) (data not shown, see also Figure 10 ).
Nucleolar E7 staining varies during the cell cycle
Immuno-gold staining of asynchronous cultures showed a wide range of nucleolar E7 staining, with some nucleoli apparently lacking the protein. It was possible that this heterogeneity of staining correlated with the phases of the cell cycle. In order to address this point, cells were synchronised by FACS sorting ( Figure 6 ) and then immuno-stained. In G 1 and S phases, E7 was clearly present in the nucleolus ( Figure  7A and B). In G 2 /M phase we observed several dierent population of cells; (i) about 20% of cells which had approximately the same levels of nucleolar E7 staining of G 1 and S phases ( Figure 7C ), (ii) 50 ± 60% of cells which had very low levels of nucleolar E7 staining ( Figure 7D and E), (iii) about 20% cells which did not show any nucleolar E7 staining ( Figure 7F ). To determine whether the decrease of E7 concentration in the nucleolus was due to a¯uctuation of the protein in the cell, we analysed the total E7 content during the cell cycle. In Figure 8 , CaSki cells were synchronised by a Nocodazol block at the M-phase and then released from the block. At the times indicated in the ®gure legend, cells were collected for FACS analysis or for immuno blotting with E7 monoclonal antibody (Triton). The level of E7 protein was approximately the same at each point analysed. Similar results were (Scheer and Weisenberger, 1994) , it is possible that this heterogeneity of E7 nucleolar staining correlates with speci®c events preceding the M-phase.
The cellular protein Rb1 is localised in the nucleolus of CaSki cells
Recently, it has been reported that Rb1, one of the E7 cellular targets, can accumulate in the nucleolus in U937 cells (Cavanaugh et al., 1995) . To test the hypothesis that E7 localisation may be linked to its interaction with Rb1 in CaSki, we performed electron Figure 9B , Rb1 was present in both nucleolus and nucleus, although a higher concentration was detected in the former compartment. The immuno-gold staining appeared to be speci®c, since it was not observed in the Saos-2 cell line which contains a cytoplasmic truncated form of Rb1 ( Figure 9A ) (Shew et al., 1990 ). We did not observe any cytoplasmic immuno-gold staining in these cells. This was probably due to the very low concentration of the Rb1 mutant in the cell (Shew et al., 1990 ) (our unpublished data). (Cochrane et al., 1990; Dang and Lee, 1989; Schmidt-Zachmann and Nigg, 1993) . The sequence of E7 does not contain any known nuclear targeting sequences. It is possible, however, that E7
HPV16 E7 protein is transported in the nucleolus
protein accumulates in the nucleolus upon binding to cellular protein(s) which serves as a shuttle into this compartment.
To exclude the eects of endogenous Rb related proteins (Rb1, p107 or p130) upon E7 transport we decided to determine the E7 localisation in ®ssion yeast S. pombe which appear to lack these proteins. HPV16 E7 gene was expressed under the control of the thiamine-dependent nmt-1 promoter (Maundrell, 1990) . The yeast synthesised E7 protein shown to have the same phosphorylation patterns as in higher eukaryotes (Tommasino et al., 1992) . Figure 10B shows that E7 is also predominantly localised in the nucleolus in the ®ssion yeast. No staining was observed in yeast cells which did not contain HPV16 E7 protein ( Figure  10A ).
Discussion
HPV16 E7 is a multifunctional protein which stimulates cellular proliferation and induces malignant transformation (Mansur and Androphy, 1993; Tommasino and Crawford, 1995) . To better understand its role in these cellular events we de®ned, by immuno¯uorescence and electron microscopy immu- no-gold staining, the intracellular localisation of E7 in the HPV16-positive cervical carcinoma cell line, CaSki. We showed that E7 was strongly associated with the nucleolus, although staining was also observed in the cytoplasm and in the nucleus. These data showed for the ®rst time the E7 cellular localisation in cells where the cellular ultra-structure is preserved and the viral oncoprotein is not ectopically expressed. The same E7 nucleolar staining pattern was observed using three dierent antibodies, two monoclonals (TVGY701 and 703, Figures 2 ± 5) and one polyclonal (Figure 10 ). None of these antibodies were able to stain nucleoli in HPVnegative cell lines, MCF7 (breast cancer derived cell), C-33A (cervical carcinoma derived cell line) and HaCat (immortalised keratinocytes), using immuno¯uorescence or electron microscopic immunogold staining (Figures 2 ± 5 and data not shown). The data on E7 localisation in mammalian cells are corroborated by the yeast data, which also show a preferential nucleolar staining pattern. The nucleolar E7 staining appears to be cell cycle dependent. Much less E7 was detected in the nucleolus during the G 2 phase prior to the disassembly of the nucleolus in mitosis. The disappearance of E7 nucleolar staining in G 2 phase is not due to a decrease of total E7 protein content in the cell since E7 is present at approximately the same level throughout the cell cycle. It is possible that speci®c events during G 2 result in a loss of E7 from the nucleolus and/or in masking of the E7 epitope. Both possibilities are currently under investigation.
Interestingly, the E7 cellular target Rb1, also appeared to be localised in the nucleolus in CaSki cells (Figure 9 ), raising the possibility that E7 nucleolar localisation may be acquired to alter the Rb1 function(s) in the nucleolus. Recently, it has been reported that Rb1 binds to the nucleolar protein, UBF, thereby preventing the activation of PolI (Cavanaugh et al., 1995) . In the same in vitro experimental system, the addition of an E7 peptide containing an Rb1 binding domain (LXCXE) was able to relieve this inhibitory eect (Cavanaugh et al., 1995) . Thus, it is possible that one of the functions of E7 is to serve as antagonist to the Rb1 function in repressing PolI transcription. The ribosomal RNAs are assembled with ribosomal proteins to form the ribosomes on which proteins are synthesised in the cytoplasm. Stimulation of ribosomal RNA synthesis might be necessary for maximal virus protein synthesis in a cell which had been quiescent before infection.
The E7 amino acid sequence does not contain any known nuclear targeting domains and may therefore be transported into the nucleolus by a shuttle nucleolar protein. The E7 protein has a similar localisation pattern in ®ssion yeast S. pombe implying conservation of the nucleolar protein(s) involved in the E7 transport throughout eukaryotes. The Rb1, p107 and p130 proteins are probably not required for such transport because they appear to be absent in yeast. The study of E7 transport in the nucleolus in yeast may facilitate the identi®cation of cellular protein(s) involved in such transport.
What is the biological signi®cance of the E7 nucleolar localisation? The identi®cation of E7 domains required for the nucleolar localisation, and their comparison with domains required for cellular transformation may answer the question.
Materials and methods
Antibodies
Monoclonal antibodies TVGY 701, 702, 703, 704. Mice were immunised twice with 50 mg of recombinant E7 protein that was expressed and puri®ed as native protein in ®ssion yeast S. pombe. Hybridomas were screened against glutathione S-transferase-E7 and yeast E7 protein ®rst by ELISA, and then by immuno-blot and immunoprecipitation. Four hybridoma were established as lines, TVGY701, TVGY702, TVGY703, TVGY704.
Other antibodies. The anti E7 polyclonal antibody, made against the MS2/E7 protein, is able to react with E7 protein in immuno blot and immunoprecipitation (Tommasino et al., 1990) .
Cell manipulation
CaSki, C33-A, HaCat, MCF-7 and Saos-2 cells were obtained from Imperial Cancer Research Fund Cell Production facilities and cultured in Dulbecco's E4 medium supplemented with 10% fetal calf serum.
For the synchronisation of the cell cycle phases, cells were sorted by FACS as described in (Tommasino et al., 1993) . For the immuno blotting analysis CaSki cells were synchronised at the M-phase by Nocodazol.
Schizosaccharomyces pombe manipulation
The leu1-32 auxotrophic mutant of S. pombe was used in all experiments. Procedures for cell culture and transformation were as described (Moreno et al., 1991) . The HPV16 E7 gene was cloned in REP3 vector under the control of an inducible promoter (Maundrell, 1993) and the synthesis of the protein in the yeast was induced as described previously (Tommasino and Maundrell, 1991) .
Indirect immuno¯uorescence labelling
For immuno¯uorescence, CaSki cells were rinsed in PBS and ®xed either with cold methanol (7208C) followed by 720 acetone for 10 min or with 2% paraformaldehyde in PBS followed by treatment with 0.1% Triton for 5 min. Then, cells were incubated with E7 antibodies (diluted 1 : 30 in PBS) for 1 h at room temperature and¯ooded by rabbit anti-mouse Cy3-conjugated IgG (Dianova, dilution 1 : 400) for 30 min. Specimens were mounted in Mowiol (Calbiochem) and studied under Axiophot epi¯uorescence microscope (Carl Zeiss; Germany) with 1006 and 636 lenses.
Electron microscopy techniques
The yeast, CaSki, C33-A, HaCat, MCF-7 and Saos-2 cells were ®xed with 4% paraformaldehyde plus 0.2% glutaraldehyde in 0.1 M Sorensens phosphate buer pH 7.4 for 2 h at room temperature. After ®xation the cells were treated with 0.5 M NH 4 Cl in phosphate buer for 4 h and washed in buer overnight. The cells were dehydrated in a graded series of methanol (50, 70, 80, 90%, 20 min for each concentration) at progressively lower temperature and in®ltrated with Lowicryl HM20 at 7508C. The resin was polymerised by u.v. light for 48 h at 7508C. For immunogold studies, ultrathin sections were mounted on carbon coated grids and were labelled as follows: the grids were preincubated 5 min in PBS and 1 h PBS containing 5% Bovin Serum Albumin (BSA) and 5% normal goat serum. The grids were then incubated overnight in PBS containing 1% BSA, 1% normal goat serum and speci®c anti E7 antibodies diluted 1/10 (monoclonal TVGY703 and anti E7 polyclonal) or anti Rb1 monoclonal antibody (C36, PharMingen). After three 15 min washes in PBS containing 1% BSA and 1% normal goat serum, the sections were incubated with immuno-gold conjugated (goat anti-mouse or anti-rabbit IgG, 5 nm gold) for 2 h. After three ®nal rinses in PBS and in distilled water of 5 min each, the sections were silver enhanced using Intensive M. Silver Enhancement Kit (Amersham) for 4 min at room temperature and contrasted with uranyl acetate and lead citrate.
Finally, the sections were examined with a Jeol 1200 FX electron microscope. As negative control the primary antibodies were omitted from the procedure to visualise any non-speci®c binding of gold particles on cell organelles.
Immuno-blot analysis
Immuno-blot analyses were performed as described (Lukas et al., 1994) using the Renaissance TM enhanced chemiluminescence detection system (DuPont). The HPV16 E7 protein was detected with MS2/E7 rabbit polyclonal antibody (Tommasino et al., 1990) (Figure 1 ) or with a monoclonal antibody (Triton) (Figure 8 ).
